|
Login
Directory:
Add Company
| Your company can benefit
from enhanced listings. Questions? Read our FAQ
first. |
Personalized notification service and newsletter info
| Subscribe (free) to get notified
of new additions. |
Learn more About us and about our Services
Contact us
|
Paclitaxel 
|
|
Readily available Recent EU registration dossier
Offer available for: licensing Pharmaceutical form and dosage: 30-100-300 mg Injection
Type:
- Generics
- Pharmaceuticals / Therapeutics
- Prescription drugs (Rx)
Therapeutic target:
- Cancer
- Oncology
Action: aanti-cancer |
|
|
Full Description:
Paclitaxel dossier:
-New readily available for licensing
-Stability: 25°C: 30 months, 40°C: 6 months
Availability and Market information:
Status: Registration
Registration info: Ma to be obtained soon
Market information
Other Market Info:
Patent Information:
Name: Taxol
Patent info: Development of pharmaceuticals which are still under patent is carried out according to EU-requirements in countries with no existing patents or with Bolar-provisions.
We deliver to all countries where the substance and its use are not protected by patents.
|
Suggestion box |
Disclaimer | Privacy
Policy | Rules & Regulations
Copyright© Cofidei, Inc. Last modified: 31-Oct-2001.
|
Add
Company
Subscribe
Search
Contact
